Septerna, Inc.
SEPNReported to SECin USCIK 0001984086Filings at SEC EDGAR
No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.
This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 24. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.
The most recent filings
Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.
| Filed by | Type | Value | Reported | Filed by | Value | Type | Shares | Reported |
|---|---|---|---|---|---|---|---|---|
| Patni RajivChief Medical Officer | Award | nothing paid275,000 shares | Sep 10, 2026 | Patni RajivChief Medical Officer | nothing paid | Award | 275,000 | Sep 10, 2026 |
| Long Daniel D.SVP, Drug Discovery | Option exercise | nothing paid3,333 shares | Sep 3, 2026 | Long Daniel D.SVP, Drug Discovery | nothing paid | Option exercise | 3,333 | Sep 3, 2026 |
| Long Daniel D.SVP, Drug Discovery | Open-market sell | $126,0783,333 shares | Sep 3, 2026 | Long Daniel D.SVP, Drug Discovery | $126,078 | Open-market sell | 3,333 | Sep 3, 2026 |
| Long Daniel D.SVP, Drug Discovery | Option exercise | $9,1993,333 shares | Sep 3, 2026 | Long Daniel D.SVP, Drug Discovery | $9,199 | Option exercise | 3,333 | Sep 3, 2026 |
| RA CAPITAL MANAGEMENT, L.P.— | Open-market sell | $31,726,250746,500 shares | Aug 14, 2026 | RA CAPITAL MANAGEMENT, L.P. | $31,726,250 | Open-market sell | 746,500 | Aug 14, 2026 |